Prolactin-secreting tumors and hypogonadism in men.
D000818:Animals; D001971:Bromocriptine / Q000494:pharmacology / Q000627:therapeutic use; D006063:Chorionic Gonadotropin / Q000494:pharmacology / Q000627:therapeutic use; D007172:Erectile Dysfunction / Q000517:prevention & control; D005260:Female; D006801:Humans; D007006:Hypogonadism / Q000097:blood / Q000517:prevention & control*; D007989:Libido / Q000187:drug effects; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D009270:Naloxone / Q000494:pharmacology / Q000627:therapeutic use; D010911:Pituitary Neoplasms / Q000503:physiopathology*; D011388:Prolactin / Q000097:blood / Q000378:metabolism*; D051381:Rats; D013739:Testosterone / Q000097:blood
D006063:Chorionic Gonadotropin; D009270:Naloxone; D001971:Bromocriptine; D013739:Testosterone; D011388:Prolactin; D007986:Luteinizing Hormone